Alcon introduces presbyopia-correcting lens implant–AcrySof IQ Vivity, first time in IndiaOctober 11, 2021
Alcon, a global leader in eye care, today announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology–-AcrySof IQ Vivity IOL in India. This new PC-IOL, which was launched in the country ahead of World Sight Day on October 14, is now available to ophthalmologists for their patients undergoing cataract surgery.
Vivity, which aims to meet the needs of cataract patients interested in enhanced visual performance, reduced spectacle dependence, is the first and only extended depth of focus lens with Alcon’s proprietary X-WAVE technology. This technology, which stretches and shifts light without splitting it, delivers a continuous range of vision at various distances like monofocal-quality distance (far) with excellent intermediate (at arm’s length, e.g., reading the newspaper, working on laptop) and functional near (up close, e.g., reading books, mobile phone), with a clinically proven exceptionally low rate of visual disturbances.
Cataracts usually impact older adults and are often linked to presbyopia, which reduces the ability to view near objects and is the most common refractive disorder in patients undergoing cataract surgery.
“Traditional IOLs typically address distance vision. However, since the new generation of seniors spend significant time with technology screens like phones, tablets and computers, and currently experience a massive gap in near and intermediate vision post-surgery,” said Shalav Modi, Country Franchise Head, Surgical, and Country Manager at Alcon Laboratories India.
“Vivity addresses this gap and the desire of patients who want to get rid of cataracts and presbyopia at the same time. As a result, patients can be less dependent on glasses for most activities, post-surgery, enhancing their visual satisfaction and quality of life,” Modi added.
Vivity expands Alcon’s growing portfolio of PC-IOLs and it is built on Alcon’s trusted and proven AcrySof IQ IOL platform with implants exceeding 125 million eyes globally. According to results from two large independent clinical trials, patients who had the Vivity lens implanted experienced renewed vision and lifestyle benefits. Vivity patients reported 20/20 vision at a distance, more than 20/25 at intermediate and 20/32 for near vision, the company said in a media release.